Epithelial membrane protein-2 in human proliferative vitreoretinopathy and epiretinal membranes

David G. Telander, Alfred K. Yu, Krisztina I. Forward, Shawn A. Morales, Lawrence S Morse, Susanna Soon Chun Park, Lynn K. Gordon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE. To determine the level of epithelial membrane protein-2 (EMP2) expression in preretinal membranes from surgical patients with proliferative vitreoretinopathy (PVR) or epiretinal membranes (ERMs). EMP2, an integrin regulator, is expressed in the retinal pigment epithelium and understanding EMP2 expression in human retinal disease may help determine whether EMP2 is a potential therapeutic target. METHODS. Preretinal membranes were collected during surgical vitrectomies after obtaining consents. The membranes were fixed, processed, sectioned, and protein expression of EMP2 was evaluated by immunohistochemistry. The staining intensity (SI) and percentage of positive cells (PP) in membranes were compared by masked observers. Membranes were categorized by their cause and type including inflammatory and traumatic. RESULTS. All of the membranes stained positive for EMP2. Proliferative vitreoretinopathy– induced membranes (all causes) showed greater expression of EMP2 than ERMs with higher SI (1.81 vs. 1.38; P = 0.07) and PP (2.08 vs. 1.54; P = 0.09). However all the PVR subgroups had similar levels of EMP2 expression without statistically significant differences by Kruskal- Wallis test. Inflammatory PVR had higher expression of EMP2 than ERMs (SI of 2.58 vs. 1.38); however, this was not statistically significant. No correlation was found between duration of PVR membrane and EMP2 expression. EMP2 was detected by RT-PCR in all samples (n = 6) tested. CONCLUSIONS. All studied ERMs and PVR membranes express EMP2. Levels of EMP2 trended higher in all PVR subgroups than in ERMs, especially in inflammatory and traumatic PVR. Future studies are needed to determine the role of EMP2 in the pathogenesis and treatment of various retinal conditions including PVR.

Original languageEnglish (US)
Pages (from-to)3112-3117
Number of pages6
JournalInvestigative Ophthalmology and Visual Science
Volume57
Issue number7
DOIs
StatePublished - Jun 1 2016

Fingerprint

Epiretinal Membrane
Proliferative Vitreoretinopathy
Membrane Proteins
Membranes
Staining and Labeling
human EMP2 protein
Retinal Diseases
Retinal Pigment Epithelium
Vitrectomy
Integrins

Keywords

  • EMP2
  • Epiretinal membrane
  • Epithelial membrane protein-2
  • Fibrosis
  • Proliferative vitreoretinopathy
  • Retinal detachment
  • Retinal pigment epithelium
  • Therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Epithelial membrane protein-2 in human proliferative vitreoretinopathy and epiretinal membranes. / Telander, David G.; Yu, Alfred K.; Forward, Krisztina I.; Morales, Shawn A.; Morse, Lawrence S; Park, Susanna Soon Chun; Gordon, Lynn K.

In: Investigative Ophthalmology and Visual Science, Vol. 57, No. 7, 01.06.2016, p. 3112-3117.

Research output: Contribution to journalArticle

Telander, David G. ; Yu, Alfred K. ; Forward, Krisztina I. ; Morales, Shawn A. ; Morse, Lawrence S ; Park, Susanna Soon Chun ; Gordon, Lynn K. / Epithelial membrane protein-2 in human proliferative vitreoretinopathy and epiretinal membranes. In: Investigative Ophthalmology and Visual Science. 2016 ; Vol. 57, No. 7. pp. 3112-3117.
@article{fe9c069920984a2c9ca5d7fdab9eae42,
title = "Epithelial membrane protein-2 in human proliferative vitreoretinopathy and epiretinal membranes",
abstract = "PURPOSE. To determine the level of epithelial membrane protein-2 (EMP2) expression in preretinal membranes from surgical patients with proliferative vitreoretinopathy (PVR) or epiretinal membranes (ERMs). EMP2, an integrin regulator, is expressed in the retinal pigment epithelium and understanding EMP2 expression in human retinal disease may help determine whether EMP2 is a potential therapeutic target. METHODS. Preretinal membranes were collected during surgical vitrectomies after obtaining consents. The membranes were fixed, processed, sectioned, and protein expression of EMP2 was evaluated by immunohistochemistry. The staining intensity (SI) and percentage of positive cells (PP) in membranes were compared by masked observers. Membranes were categorized by their cause and type including inflammatory and traumatic. RESULTS. All of the membranes stained positive for EMP2. Proliferative vitreoretinopathy– induced membranes (all causes) showed greater expression of EMP2 than ERMs with higher SI (1.81 vs. 1.38; P = 0.07) and PP (2.08 vs. 1.54; P = 0.09). However all the PVR subgroups had similar levels of EMP2 expression without statistically significant differences by Kruskal- Wallis test. Inflammatory PVR had higher expression of EMP2 than ERMs (SI of 2.58 vs. 1.38); however, this was not statistically significant. No correlation was found between duration of PVR membrane and EMP2 expression. EMP2 was detected by RT-PCR in all samples (n = 6) tested. CONCLUSIONS. All studied ERMs and PVR membranes express EMP2. Levels of EMP2 trended higher in all PVR subgroups than in ERMs, especially in inflammatory and traumatic PVR. Future studies are needed to determine the role of EMP2 in the pathogenesis and treatment of various retinal conditions including PVR.",
keywords = "EMP2, Epiretinal membrane, Epithelial membrane protein-2, Fibrosis, Proliferative vitreoretinopathy, Retinal detachment, Retinal pigment epithelium, Therapy",
author = "Telander, {David G.} and Yu, {Alfred K.} and Forward, {Krisztina I.} and Morales, {Shawn A.} and Morse, {Lawrence S} and Park, {Susanna Soon Chun} and Gordon, {Lynn K.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1167/iovs.15-17791",
language = "English (US)",
volume = "57",
pages = "3112--3117",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "7",

}

TY - JOUR

T1 - Epithelial membrane protein-2 in human proliferative vitreoretinopathy and epiretinal membranes

AU - Telander, David G.

AU - Yu, Alfred K.

AU - Forward, Krisztina I.

AU - Morales, Shawn A.

AU - Morse, Lawrence S

AU - Park, Susanna Soon Chun

AU - Gordon, Lynn K.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - PURPOSE. To determine the level of epithelial membrane protein-2 (EMP2) expression in preretinal membranes from surgical patients with proliferative vitreoretinopathy (PVR) or epiretinal membranes (ERMs). EMP2, an integrin regulator, is expressed in the retinal pigment epithelium and understanding EMP2 expression in human retinal disease may help determine whether EMP2 is a potential therapeutic target. METHODS. Preretinal membranes were collected during surgical vitrectomies after obtaining consents. The membranes were fixed, processed, sectioned, and protein expression of EMP2 was evaluated by immunohistochemistry. The staining intensity (SI) and percentage of positive cells (PP) in membranes were compared by masked observers. Membranes were categorized by their cause and type including inflammatory and traumatic. RESULTS. All of the membranes stained positive for EMP2. Proliferative vitreoretinopathy– induced membranes (all causes) showed greater expression of EMP2 than ERMs with higher SI (1.81 vs. 1.38; P = 0.07) and PP (2.08 vs. 1.54; P = 0.09). However all the PVR subgroups had similar levels of EMP2 expression without statistically significant differences by Kruskal- Wallis test. Inflammatory PVR had higher expression of EMP2 than ERMs (SI of 2.58 vs. 1.38); however, this was not statistically significant. No correlation was found between duration of PVR membrane and EMP2 expression. EMP2 was detected by RT-PCR in all samples (n = 6) tested. CONCLUSIONS. All studied ERMs and PVR membranes express EMP2. Levels of EMP2 trended higher in all PVR subgroups than in ERMs, especially in inflammatory and traumatic PVR. Future studies are needed to determine the role of EMP2 in the pathogenesis and treatment of various retinal conditions including PVR.

AB - PURPOSE. To determine the level of epithelial membrane protein-2 (EMP2) expression in preretinal membranes from surgical patients with proliferative vitreoretinopathy (PVR) or epiretinal membranes (ERMs). EMP2, an integrin regulator, is expressed in the retinal pigment epithelium and understanding EMP2 expression in human retinal disease may help determine whether EMP2 is a potential therapeutic target. METHODS. Preretinal membranes were collected during surgical vitrectomies after obtaining consents. The membranes were fixed, processed, sectioned, and protein expression of EMP2 was evaluated by immunohistochemistry. The staining intensity (SI) and percentage of positive cells (PP) in membranes were compared by masked observers. Membranes were categorized by their cause and type including inflammatory and traumatic. RESULTS. All of the membranes stained positive for EMP2. Proliferative vitreoretinopathy– induced membranes (all causes) showed greater expression of EMP2 than ERMs with higher SI (1.81 vs. 1.38; P = 0.07) and PP (2.08 vs. 1.54; P = 0.09). However all the PVR subgroups had similar levels of EMP2 expression without statistically significant differences by Kruskal- Wallis test. Inflammatory PVR had higher expression of EMP2 than ERMs (SI of 2.58 vs. 1.38); however, this was not statistically significant. No correlation was found between duration of PVR membrane and EMP2 expression. EMP2 was detected by RT-PCR in all samples (n = 6) tested. CONCLUSIONS. All studied ERMs and PVR membranes express EMP2. Levels of EMP2 trended higher in all PVR subgroups than in ERMs, especially in inflammatory and traumatic PVR. Future studies are needed to determine the role of EMP2 in the pathogenesis and treatment of various retinal conditions including PVR.

KW - EMP2

KW - Epiretinal membrane

KW - Epithelial membrane protein-2

KW - Fibrosis

KW - Proliferative vitreoretinopathy

KW - Retinal detachment

KW - Retinal pigment epithelium

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84975029542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975029542&partnerID=8YFLogxK

U2 - 10.1167/iovs.15-17791

DO - 10.1167/iovs.15-17791

M3 - Article

VL - 57

SP - 3112

EP - 3117

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 7

ER -